ABO blood group and neurodegenerative disorders: more than a casual association.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Individuals with ABO Groups Show Significant Differences in Levels of Circulating Biomarkers Related to Inflammation, Apoptosis, Endothelial Dysfunction, Tissue Remodeling and Neurodegeneration: A Pilot Study.Diseases (Basel, Switzerland) · 2026
   Article
2. Cytokine Gene Polymorphisms Modulate Isohemagglutinin Titers and Classes: Another Aspect Towards the Link Between ABO Groups and Human Pathologies?International journal of molecular sciences · 2026
   Article
3. Pediatric ABO blood groups and disease distribution: a retrospective analysis.Translational pediatrics · 2026
   Article
4. The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer's Disease.Neuroscience insights · 2020
   Review
5. O blood type is a risk factor for upper gastrointestinal bleeding.Journal of thrombosis and thrombolysis · 2018
   Article
6. Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.Blood transfusion = Trasfusione del sangue · 2017
   Article
7. ABO blood group distributions in multiple sclerosis patients from Basque Country; OMultiple sclerosis journal - experimental, translational and clinical
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as